期刊文献+

反义RNA抑制Ezrin表达对乳腺癌细胞侵袭能力的影响 被引量:3

Anti-sense RNA inhibits the expression of Ezrin and invasion of breast cancer cells
原文传递
导出
摘要 目的观察特异性阻断Ezrin的表达对人乳腺癌细胞MDA—MB-231和MCF-7的增殖和侵袭能力的影响。方法将anti—pCR3.1-Ezrin质粒经脂质体介导,转染人人乳腺癌细胞MDA—MB-2316、12和24h,应用Westernblot和逆转录-聚合酶链反应(RT—PCR)方法检测Ezrin的表达变化情况;转染质粒24h后,噻唑蓝(MTF)比色法检测抑制Ezrin对MDA—MB-231和MCF-7细胞体外增殖能力的影响,Boyden小室法检测抑制Ezrin对MDA—MB-231和MCF-7细胞体外侵袭能力的影响。结果转染anti—pCR3.1-Ezrin后,对MDA—MB-231细胞中的Ezrin表达抑制在24h时达高峰。MTY法比色实验结果显示,MDA—MB-231和MCF-7细胞中转染anti—pCR3.1-Ezrin组、转染空质粒组和对照组的A值分别为0.410±0.018、0.765±0.058、0.795±0.061和0.480±0.021、0.632±0.052、0.648±0.059。转染anti—pCR3.1.Ezrin组细胞的增殖受到明显抑制,抑制率分别为(47.9±3.1)%和(32.0±2.8)%(P〈0.05)。Boyden小室法检测结果显示,MDA—MB-231和MCF-7细胞中转染anti—pCR3.1-Ezrin组细胞的侵袭能力分别为对照组的(50.5±3.2)%和(74.8±4.6)%(P〈0.05)。结论Ezrin在乳腺癌的牛长和侵袭过程中发挥蕈要作用。 Objective To observe the influence of proliferation and invasion of human breast cancer cells MDA-MB-231 after inhibition of Ezrin expression by anti-sense RNA. Methods Human breast cancer cell lines MDA-MB-231 and MCF-7 were transfeeted with anti-pCR3. 1-Ezrin with lipofeetamine. Western-blot and RT-PCR were used to detect the expression of Ezrin after transfection for 6, 12, and 24 h, respectively. The proliferative ability of cells was tested by MTT assay, and the metastatic ability of cells was investigated by Boyden cabin after transfection for 24 h. Results After transfection with anti-sense RNA for 24 h, both protein and mRNA expression of Ezrin in MDA-MB-231 cells was significantly reduced at their peak time. After transfection with anti-sense RNA for 24 h, the MTT assay showed that absorbance (A) values in anti-pCR3.1 -Ezrin, vacuity plasmid and blank control groups were 0.410 ± 0.018,0. 765 ±0. 058,0. 795± 0. 061 in MDA-MB-231, and 0. 480± 0. 021,0. 632 ± 0. 052,0. 648 ± 0. 059 in MCF-7, respectively. The results suggested that the proliferation of MDA-MB-231 and MCF-7 cells was inhibited significantly in anti-pCR3.1 -Ezrin group by (47.9± 3.1 ) % and ( 32.0 ±2.8 ) % , respectively. After transfection with anti-sense RNA for 24 h, the invasive ability of MDA-MB-231 and MCF- 7 cells was ( 50.5± 3.2 ) % and ( 74.8 ±4.6 ) % respectively as compared with that of blank control group ( P 〈 0. 05 ). Conclusion Ezrin plays an important role in the process of proliferation and invasion of breast cancer cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第4期425-427,共3页 Chinese Journal of Experimental Surgery
基金 河北省普通高校强势特色学科肿瘤学建设资助项目(200552)
关键词 乳腺肿瘤 反义RNA 侵袭 EZRIN Breast neoplasm Antisense RNA Invasion Ezrin
  • 相关文献

参考文献9

二级参考文献32

共引文献21

同被引文献20

  • 1张水军,李文涛,周闯,赵龙拴,范正军.抑癌基因TSLC1在肝癌组织中的表达及临床意义[J].中华实验外科杂志,2007,24(2):185-186. 被引量:9
  • 2Liang QL, Chen GQ, Li ZY, et al. Function and histopathology of a cell adhesion molecule TSLC1 in cancer. Cancer Invest, 2011,29: 107- 112.
  • 3Liang QL, Wang BR, Li ZY, et 81. Construction of eukaryotic expres- sion vector of TSLC1 gene. Arch Med Sci,2011,7 :579-585.
  • 4Liang QL, Wang BR, Li ZY, et al. Effect of TSLC1 gene on growth and apoptosis in human esophageal carcinoma Ecal09 cells. Arch Med Sci ,2012,8:987-992.
  • 5Liang QL, Wang BR, Li ZY, et al. Effect of TSLC1 gene on growth and apoptosis in human esophageal carcinoma Ecal09 ceils. Arch Med Sci,2012, 8 :987 -992.
  • 6Liang QL, Li ZY, Zhou Y, et al. Construction of a Recombinant Eu- karyotic Expression vector Containing PHD3 Gene and Its Expression in HepG2 Ceils. J Exp Clin Cancer Res,2012,31:64.
  • 7Choy B, Bandla S, Xia Y, et al. Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroentero1,2012,12 : 146.
  • 8Liang QL, Chen GQ, Li ZY, et al. Function and histopathology of a cell adhesion molecule TSLC1 in cancer. Cancer Invest, 2011,29 : 107-112.
  • 9Liang QL,Wang BR,Li ZY’et al. Effect of TSLC1 gene on growth andapoptosis in human esophageal carcinoma Ecal09 cells [J]. Arch MedSci,2012,8(6) :987-992.
  • 10夏远鹏,周昱男,胡波.Bmi-1在神经母细胞瘤中的表达及意义[J].中华实验外科杂志,2008,25(3):381-383. 被引量:5

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部